Pertussis challenge study with delayed antibiotic treatment
Treatments studied
This study tests how well a “delayed antibiotic” plan works after being intentionally exposed to pertussis (whooping cough). It aims to learn whether delaying antibiotics for a short time is safe and useful, and you may be treated with an antibiotic if you become symptomatic.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be a healthy adult age 18 to 55
- Be fluent in English and able to communicate by phone, email, and text
- Be willing to follow infection-control rules and contact instructions for 6 weeks
- Agree to go to the NIHR clinic right away if you develop symptoms
- Be willing to take azithromycin/other macrolide antibiotics if the protocol requires it
- Score correctly on the pre-consent questionnaire
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests what happens when healthy adults are exposed to a special type of whooping cough bacteria. Results may help develop better vaccines to protect people from this infection.
This study looks at children with suspected pertussis (who need a PCR test) and compares how the bacteria and the immune response relate to how sick they become. It may help doctors understand why some children have worse symptoms and guide future care.
This trial tests a reduced-dose vaccine that protects against diphtheria, tetanus, and whooping cough (pertussis). It is designed for people 6 years and older who have not recently received other vaccines and are generally healthy.
This study checks on people who got a single dose of a whooping cough vaccine about 10 years ago in a previous study. Researchers want to see how well the vaccine is still working and if it is still safe.
This trial studies children who might have pertussis (“whooping cough”). It looks at children in outpatient/home-care settings when the child’s doctor suspects pertussis and orders a lab test, to help guide evaluation and care.
This trial tests a new vaccine called GC3111B to see if it is safe and helps the body build protection against diphtheria, tetanus, and pertussis (whooping cough). It is for healthy adults who have not had a similar vaccine in the last 2 years.
Hear when a new Healthy Volunteer Study trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.